Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer Therapy
New breast cancer therapy data have been reported by scientists at University Hospital, Department of Pharmacy
February 1st, 2007
New research, "Clinical and economic impact of epoetin in adjuvant-chemotherapy for breast cancer," is the subject of a report. According to a study from France, "Anaemia is a common toxicity in cancer patients and epoetins (EPOs) are now an established treatment. The economic profile of EPO treatment was assessed in patients with breast cancer treated by adjuvant-chemotherapy. Two strategies were compared: without treatment by EPO and with the possible use of treatment by EPO (epoetin alfa) when required." "The clinical effectiveness criterion was time adjusted to quality of life and economic data included only direct medical costs. One hundred ninety-two patients were...
Source: Women's Health Weekly (2007-02-01)
|
